The Lupus Research Alliance (LRA) is accepting Letters of Intent (LOIs) to support creative scientists from all relevant scientific disciplines to provide them robust and sustained support to explore bold and paradigm-shifting ideas that could lead to ground-breaking discoveries in lupus research. The Distinguished Innovator Awards provide outstanding scientists with substantial support to conduct novel research into the fundamental causes of systemic lupus erythematosus and so provide new directions towards a cure. Award amount up to $250,000 per year for up to four (4) years. The LOI deadline is March 16, 2020.


The Lupus Research Alliance (LRA) is accepting Letters of Intent (LOIs) to support creative scientists from all relevant scientific disciplines to provide them robust and sustained support to explore bold and paradigm-shifting ideas that could lead to ground-breaking discoveries in lupus research. The Distinguished Innovator Awards provide outstanding scientists with substantial support to conduct novel research into the fundamental causes of systemic lupus erythematosus and so provide new directions towards a cure. Award amount up to $250,000 per year for up to four (4) years. The LOI deadline is March 16, 2020.

The UNC-Chapel Hill Office of Corporate and Foundation Relations would like to share the following private funding opportunity:

Lupus Research Alliance: Dr. William E. Paul Distinguished Innovator Award in Lupus and Autoimmunity
http://www.lupusresearch.org

Award Amount: up to $250,000 per year for up to four (4) years
LOI Deadline: March 16, 2020
Anticipated Award Notification: October 2020
Anticipated Award Start Date: November 2020
RFP Synopsis:

The Lupus Research Alliance (LRA) is accepting Letters of Intent (LOIs) to support creative scientists from all relevant scientific disciplines to provide them robust and sustained support to explore bold and paradigm-shifting ideas that could lead to ground-breaking discoveries in lupus research. Investigators working in areas of outside of lupus are strongly encouraged to apply. The Distinguished Innovator Awards provide outstanding scientists with substantial support to conduct novel research into the fundamental causes of systemic lupus erythematosus and so provide new directions towards a cure. The Lupus Research Alliance welcomes novel, hypothesis- or discovery-driven proposals using clinically relevant models in lupus research. The research proposal must aim to uncover the fundamental causes of lupus and present a compelling vision of how the discovery would lay the groundwork for a cure, prevention, or highly effective therapy. In keeping with the strategic research objectives of the LRA, priority consideration will be given to projects that address understanding of lupus heterogeneity or patient stratification by active disease mechanism or employing global research and technological partnerships to address these priority areas. Applicants must hold a faculty position, at the assistant professor level or above, at an academic institution. Only one LOI will be accepted per principal investigator in a grant cycle. Indirect costs are not allowed for this grant.

To read the full application guidelines, including detailed eligibility requirements, please visit: https://www.lupusresearch.org/research-and-clinical-trials/research/funding-opportunities/.

The UNC-Chapel Hill Office of Corporate and Foundation Relations is available to assist UNC personnel pursuing privately funded opportunities. If you have any questions about this funding opportunity, please email cfr@unc.edu or call 919.962.2867.